Review
. 2021 Apr;9(2):e00761.
doi: 10.1002/prp2.761.
Affiliations
- PMID: 33822478
- DOI: 10.1002/prp2.761
Abstract
The development of multidrug-resistant bacteria has revealed the need for new antimicrobial compounds. Cannabis sativa preparations have a long history of medical applications, including the treatment of infectious diseases. This review collects the information about the activity of C. sativa extracts and its main components (cannabinoids and terpenes) against pathogenic bacteria and fungus, to assess its potential using as antimicrobial agents.
Keywords: Cannabis sativa, antimicrobial activity, cannabinoids, terpenes
© 2021 The Authors. Pharmacology Research & Perspectives published by British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics and John Wiley & Sons Ltd.
Similar articles
-
Isolation, Purification, and Antimicrobial Characterization of Cannabidiolic Acid and Cannabidiol from Cannabis sativa L.Biomolecules. 2020 Jun 12;10(6):900. doi: 10.3390/biom10060900.PMID: 32545687 Free PMC article.
-
Chemical Characterization and Evaluation of the Antibacterial Activity of Essential Oils from Fibre-Type Cannabis sativa L. (Hemp).Molecules. 2019 Jun 21;24(12):2302. doi: 10.3390/molecules24122302.PMID: 31234360 Free PMC article.
-
Comprehensive quality evaluation of medical Cannabis sativa L. inflorescence and macerated oils based on HS-SPME coupled to GC-MS and LC-HRMS (q-exactive orbitrap®) approach.J Pharm Biomed Anal. 2018 Feb 20;150:208-219. doi: 10.1016/j.jpba.2017.11.073. Epub 2017 Dec 22.PMID: 29247961
-
Cannabis Sativa L.: a comprehensive review on the analytical methodologies for cannabinoids and terpenes characterization.J Chromatogr A. 2021 Jan 25;1637:461864. doi: 10.1016/j.chroma.2020.461864. Epub 2020 Dec 30.PMID: 33422797 Review.
-
Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history.J Ethnopharmacol. 2018 Dec 5;227:300-315. doi: 10.1016/j.jep.2018.09.004. Epub 2018 Sep 8.PMID: 30205181 Review.
References
REFERENCES
-
- Martens E, Demain AL. The antibiotic resistance crisis, with a focus on the United States. J Antibiot. 2017;70(5):520-526. https://doi.org/10.1038/ja.2017.30
-
- Levy SB, Marshall B. Antibacterial resistance worldwide: causes, challenges and responses. Nat Med. 2004;10(12 Suppl):S122-S129. https://doi.org/10.1038/nm1145
-
- Andrei S, Valeanu L, Chirvasuta R, Stefan MG. New FDA approved antibacterial drugs: 2015-2017. Discoveries. 2018;6(1):e81. https://doi.org/10.15190/d.2018.1
-
- Rios AC, Moutinho CG, Pinto FC, et al. Alternatives to overcoming bacterial resistances: state-of-the-art. Microbiol Res. 2016;191:51-80. https://doi.org/10.1016/j.micres.2016.04.008
-
- Nascimento GGF, Freitas PC, Silva GL. Antibacterial activity of plant extracts and phytochemicals on antibiotic-resistant bacteria. Braz J Microbiol. 2000;31(4):247-256. https://doi.org/10.1590/s1517-83822000000400003
Publication types
